Reappearance of Effector T Cells Predicts Successful Recovery from COVID-19

Submitted by Anonymous (not verified) on

paper: Odak, I., Barros-Martins, J., Bošnjak, B., Stahl, K., David, S., Wiesner, O., ... & Schultze-Florey, C. R. (2020). Reappearance of effector T cells is associated with recovery from COVID-19. EBioMedicine, 57, 102885.
contributor: Christian Schultze-Florey
contributor_organization: Hannover Medical School
contributor_email: schultze-florey.christian@mh-hannover.de

 

Systematic examination of T cell responses to SARS-CoV-2 versus influenza virus reveals distinct inflammatory profile

Submitted by Anonymous (not verified) on

paper: Law, J. C., Koh, W. H., Budylowski, P., Lin, J., Yue, F., Abe, K. T., ... & Ostrowski, M. A. (2020). Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile. The Journal of Immunology, 206(1), 37-50.
contributor: Tania H. Watts
contributor_organization: University of Toronto
contributor_email: tania.watts@utoronto.ca

 

Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients

Submitted by Anonymous (not verified) on

paper: Pierce, C.A., Preston-Hurlburt, P., Dai, Y., Aschner, C.B., Cheshenko, N., Galen, B., Garforth, S., Herrera, N.G., Jangra, R., Morano, N.C., Orner, E., Sy, S., Chandran, K., Dziura, J., Almo, S., Ring, A., Keller, M., Herold, K., & Herold, B. (2020). Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Science Translational Medicine, 12.
contributor: Kevan Herold
contributor_organization: Yale University
contributor_email: kevan.herold@yale.edu

 

A granulocytic signature identifies COVID-19 and its severity

Submitted by Anonymous (not verified) on

paper: Vitte, J., Diallo, A. B., Boumaza, A., Lopez, A., Michel, M., Allardet-Servent, J., Mezouar, S., Sereme, Y., Busnel, J. M., Miloud, T., Malergue, F., Morange, P. E., Halfon, P., Olive, D., Leone, M., & Mege, J. L. (2020). A Granulocytic Signature Identifies COVID-19 and Its Severity. The Journal of infectious diseases, 222(12), 1985–1996. https://doi.org/10.1093/infdis/jiaa591
contributor: Marc Leone
contributor_organization: Aix-Marseille University
contributor_email: marc.leone@ap-hm.fr

 

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.

Submitted by Anonymous (not verified) on

paper: Woodruff, M. C., Ramonell, R. P., Nguyen, D. C., Cashman, K. S., Saini, A. S., Haddad, N. S., ... & Sanz, I. (2020). Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nature immunology, 21(12), 1506-1516.
contributor: Matthew C. Woodruff
contributor_organization: Emory University
contributor_email: mcwoodr@emory.edu

 

Two distinct immunopathological profiles in autopsy lungs of COVID-19.

Submitted by Anonymous (not verified) on

paper: Nienhold, R., Ciani, Y., Koelzer, V. H., Tzankov, A., Haslbauer, J. D., Menter, T., ... & Mertz, K.D. (2020). Two distinct immunopathological profiles in autopsy lungs of COVID-19. Nature communications, 11(1), 1-13.
contributor: Kirsten D. Mertz
contributor_organization: Cantonal Hospital Baselland
contributor_email: kirsten.mertz@ksbl.ch

 

Longitudinal analyses reveal immunological misfiring in severe COVID-19.

Submitted by Anonymous (not verified) on

paper: Lucas, C., Wong, P., Klein, J., Castro, T. B., Silva, J., Sundaram, M., ... & Iwasaki, A. (2020). Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature, 584(7821), 463-469.
contributor: Carolina Lucas
contributor_organization: Yale University
contributor_email: carolina.lucas@yale.edu

 

Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report.

Submitted by Anonymous (not verified) on

paper: Paliogiannis, P., Zinellu, A., Scano, V., Mulas, G., De Riu, G., Pascale, R. M., Arru, L. B., Carru, C., Pirina, P., Mangoni, A. A., & Fois, A. G. (2020). Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report. Journal of infection in developing countries, 14(7), 685–690. https://doi.org/10.3855/jidc.12879
contributor: Panagiotis Paliogiannis
contributor_organization: Università degli Studi di Sassari
contributor_email: ppaliogiannis@uniss.it

 

Natural killer cell immunotypes related to COVID-19 disease severity.

Submitted by Anonymous (not verified) on

paper: Maucourant, C., Filipovic, I., Ponzetta, A., Aleman, S., Cornillet, M., Hertwig, L., ... & Björkström NK. (2020). Natural killer cell immunotypes related to COVID-19 disease severity. Science immunology, 5(50).
contributor: Niklas K. Björkström
contributor_organization: Karolinska Institutet
contributor_email: niklas.bjorkstrom@ki.se